Literature DB >> 3344560

Local microwave hyperthermia in treatment of advanced prostatic adenocarcinoma.

S Szmigielski1, H Zielinski, B Stawarz, J Gil, J Sobczynski, G Sokolska, J Jeljaszewicz, G Pulverer.   

Abstract

Fifteen patients with advanced (T3-4, Nx-2, M0-1) prostatic adenocarcinoma were treated with local microwave hyperthermia (LMwH) applied as the sole method of therapy (automatically controlled set generating 2,450 MHz microwaves with intrarectal applicator). All patients were monitored with a battery of tests, including USG image and volumetry of prostate, bone scintigraphy, serum alkaline phosphatase and serum level of PAP. LMwH sessions were well tolerated and did not cause pain except a moderate sensation of heating in the pelvic region. 8 of these 15 patients responded to the therapy (3x complete remission and 5x partial remission). Involution of the prostatic tumor in responders was accompanied by improvement of the general clinical and urological state. In two responders bone metastases, documented scintigraphically before therapy, disappeared. 7 patients did not respond to LMwH, mostly patients with very large primary tumors.

Entities:  

Mesh:

Year:  1988        PMID: 3344560     DOI: 10.1007/bf00264620

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  16 in total

1.  New strategies of immunotherapy.

Authors:  J W Hadden; F Spreafico
Journal:  Springer Semin Immunopathol       Date:  1985

2.  A generalized concept for cell killing by heat.

Authors:  H Jung
Journal:  Radiat Res       Date:  1986-04       Impact factor: 2.841

3.  Thermoimmunotherapy of advanced neoplasms. A concept and preliminary results.

Authors:  S Szmigielski; J Jeljaszewicz; G Pulverer
Journal:  Biomed Pharmacother       Date:  1987       Impact factor: 6.529

Review 4.  Hyperthermia in cancer therapy: the biological basis and unresolved questions.

Authors:  L E Gerweck
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

Review 5.  Treatment of advanced cancer of the prostate.

Authors:  G D Chisholm
Journal:  Semin Surg Oncol       Date:  1985

6.  Immunotherapeutic agents: their role in cellular immunity and their therapeutic potential.

Authors:  M A Chirigos; J E Talmadge
Journal:  Springer Semin Immunopathol       Date:  1985

7.  Thermotolerance: a review of observations and possible mechanisms.

Authors:  S B Field; R L Anderson
Journal:  Natl Cancer Inst Monogr       Date:  1982-06

8.  Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia.

Authors:  A Yerushalmi; Y Fishelovitz; D Singer; I Reiner; J Arielly; Y Abramovici; R Catsenelson; E Levy; A Shani
Journal:  J Urol       Date:  1985-05       Impact factor: 7.450

9.  The clinical efficacy of localized hyperthermia.

Authors:  J L Meyer
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

10.  The importance of thermotolerance for the clinical treatment with hyperthermia.

Authors:  J Overgaard; O S Nielsen
Journal:  Radiother Oncol       Date:  1983-11       Impact factor: 6.280

View more
  1 in total

1.  Hyperthermia induced NFkappaB mediated apoptosis in normal human monocytes.

Authors:  Natarajan Aravindan; Karthigayan Shanmugasundaram; Mohan Natarajan
Journal:  Mol Cell Biochem       Date:  2009-02-15       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.